Jupiter Neurosciences, Inc. Made Big Gain
Wed, Jun 11, 2025 at 07:25 PM
Jupiter Neurosciences, Inc. (JUNS:NASDAQ) rocketted at $1.99, a gain of 105.8%. On Wed, Jun 11, 2025, JUNS:NASDAQ hit a New 2-Week High of $1.99. The stock appeared on our News Catalysts scanner on Mon, Jun 09, 2025 at 08:48 AM in the 'BIOTECH' category. From Wed, May 28, 2025, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Thu, Dec 19, 2024 at $19.51 with a volume of 1M+.
About Jupiter Neurosciences, Inc. (JUNS:NASDAQ)
Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation.
Top 10 Gainers:
- Catheter Precision, Inc. (VTAK:NYSEMKT), 165.06%
- Jupiter Neurosciences, Inc. (JUNS:NASDAQ), 105.79%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 81.53%
- 707 Cayman Holdings Limited (JEM:NASDAQ), 73.07%
- XTI Aerospace, Inc. (XTIA:NASDAQ), 65.57%
- Distoken Acquisition Corporation (DIST:NASDAQ), 64.17%
- Kindly MD Inc. (NAKA:NASDAQ), 58.1%
- Nuwellis, Inc. (NUWE:NASDAQ), 57.56%
- INNEOVA Holdings Limited (INEO:NASDAQ), 53.45%
- mF International Limited (MFI:NASDAQ), 46.32%